Eli Lilly's quarter was messy. What to do with the stock is more clear-cut
Read more at CNBC
Topics
-
Jim Cramer identifies an interesting buy level for our worst performing Big Tech stock this year
Business - CNBC - October 31 -
Lilly’s Mounjaro, Zepbound drugs see strong demand. So why did sales disappoint?
Business - MarketWatch - October 30 -
Eli Lilly stock tumbles after drug giant misses estimates and slashes profit guidance
Business - CNBC - October 30 -
Here's why Eli Lilly bounced back, plus mega-caps lag while staples stocks rise
Business - CNBC - Yesterday -
Eli Lilly to trial use of weight loss drugs to combat unemployment in UK
Business - CNBC - October 15
More from CNBC
-
What Trump's mass deportation plan would mean for immigrant workers and the economy
Business - CNBC - 2 hours ago -
Bitcoin hits $80,000 for the first time as crypto traders bask in Trump election victory
Business - CNBC - 4 hours ago -
Fed's Kashkari says Trump tariffs could reheat inflation if they provoke global trade 'tit for tat'
Business - CNBC - 54 minutes ago -
'#EndtheFed': Elon Musk endorses plan to let presidents meddle with Federal Reserve after Trump election win
Business - CNBC - 21 hours ago -
Trump ‘most likely’ needs 60 votes in Senate to enact tariff plan, Sen. Rick Scott suggests
Business - CNBC - 36 minutes ago
Latest in Business
-
Trump ‘most likely’ needs 60 votes in Senate to enact tariff plan, Sen. Rick Scott suggests
Business - CNBC - 36 minutes ago -
Fed's Kashkari says Trump tariffs could reheat inflation if they provoke global trade 'tit for tat'
Business - CNBC - 54 minutes ago -
Fate of postelection stock-market rally may be in the hands of bond traders
Business - MarketWatch - 1 hour ago -
What Trump's mass deportation plan would mean for immigrant workers and the economy
Business - CNBC - 2 hours ago -
Ben Baldanza, 62, Dies; Brought No-Frills Flying to Spirit Airlines
Business - The New York Times - 2 hours ago